3i divests interest in Centrul Medical Unirea
3i, an international leader in private equity, has agreed to divest its 48.7% shareholding in Romanian based Centrul Medical Unirea (“CMU”) to Advent International, a global private equity firm.
CMU is a leading chain of medical clinics based in Romania, providing ambulatory and inpatient medical services through a network of clinics (11 in Bucharest and 8 in other locations), a maternity unit in Regina Maria and a separate surgical unit.
Founded in 1995 by Dr Wargha Enayati, 3i, advised by 3TS Capital Partners invested in CMU in 2007. Supported by both 3i and 3TS Capital Partners, CMU has achieved successful growth through increasing the breadth of its regional footprint and expanding its range of specialist services, including the addition of a specialist maternity hospital, stem cell bank services, a dedicated diagnostics centre with highly advanced MRI and CT equipment and a paediatrics policlinic. Estimated revenues for CMU in 2010 are €21 million.
3i have a long track record of investment in the healthcare space. Current investments include the leading European wide diagnostics and laboratory services business Labco, as well as contract research outsourcing provider Quintiles Transnational and Axellia, a Nordic based worldwide supplier and developer of active pharmaceutical ingredients.
Daniel Lynch, Managing Partner at 3TS Capital said: “Centrul Medical Unirea has all the ingredients of a great business: visionary founder, talented management team and well thought strategy. Dr Enayati has been not only a successful businessman but a great partner and we look forward to following the developments of the company through its next stage of growth."
Rowena Cahill, 3i investment executive said: “Under the leadership and vision of Dr Enayati and with the support of 3i , Centrul Medical Unirea has delivered significant growth throughout the past 3 years, expanding both its product offering and regional platform. We are confident that the business will continue its great success going forward.”
Notes to editors
3i is a FTSE100 company and an international leader in private equity. We focus on buyouts, growth capital and infrastructure and invest across Europe, Asia and North America. Our competitive advantage comes from our international network and the strength and breadth of our business relationships. These underpin the value that we deliver to our portfolio, shareholders and investors.
3i's healthcare team has invested over €1.6bn in 36 healthcare companies since April 2001 across Europe, North America and Asia. We invest in Pharmaceuticals, Medical Technology and Healthcare Services companies led by management teams with a strong track record and the ambition to build lasting value. 3i's recent investments in the healthcare sector include: Quintiles Transnational, Axellia (formerly Alpharma API) and LHi Technology.
About 3ts Capital Partners
3TS Capital Partners is one of the leading private equity and venture capital firms in Central and Eastern Europe operating in the whole region through offices in Budapest, Bucharest, Prague, Vienna and Warsaw.
For further information please contact:
tel. +44207 975 3044